Pharmacokinetic and pharmacodynamic evaluation of linagliptin in African American patients with type 2 diabetes mellitus

AIM: This was an open label, multicentre phase I trial to study the pharmacokinetics and pharmacodynamics of the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin in African American patients with type 2 diabetes mellitus (T2DM). METHODS: Forty-one African American patients with T2DM were include...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Friedrich, Christian, Glund, Stephan, Lionetti, Dominick, Kissling, C James, Righetti, Julian, Patel, Sanjay, Graefe-Mody, Ulrike, Retlich, Silke, Woerle, Hans-Juergen
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2013
Assuntos:
Pharmacokinetic Dynamic Relationships
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769671/
https://ncbi.nlm.nih.gov/pubmed/23331248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12077
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados